{
  "ptid_time": "005_S_4910_2012-12-13",
  "img_path": "/data/qiuhui/data/adni/images/005_S_4910/2012-12-13/t1.nii.gz",
  "img_finding": "Image findings: ventricular volume measures 54,427 mm³, 47.2% above the reference mean. With a Z-score of 1.28 (89.9th percentile), this represents mild enlargement; hippocampal volume measures 4,773 mm³, 26.5% below the reference mean. With a Z-score of -2.12 (1.7th percentile), this represents significant atrophy; whole brain volume measures 809,069 mm³, 12.8% below the reference mean. With a Z-score of -1.54 (6.2th percentile), this represents moderate atrophy; entorhinal cortex volume measures 1,443 mm³, 58.3% below the reference mean. With a Z-score of -3.15 (0.1th percentile), this represents profound atrophy; fusiform gyrus volume measures 10,887 mm³, 32.4% below the reference mean. With a Z-score of -2.44 (0.7th percentile), this represents significant atrophy; middle temporal gyrus volume measures 11,204 mm³, 37.9% below the reference mean. With a Z-score of -3.37 (0.0th percentile), this represents profound atrophy. ",
  "text_data": "Age is 81.4 years. Gender is Female. Education: 15 years. Handedness: Right. Race: White. Medical history: Head, Eyes, Ears, Nose and Throat; Dermatologic-Connective Tissue; Musculoskeletal; Endocrine-Metabolic; Renal-Genitourinary; Allergies or Drug Sensitivities; Smoking; Major Surgical Procedures. MMSE: 25.0. MoCA: 13.0. Logical Memory: 2.0. APOEε4 alleles: 0.0. Biomarker levels: Florbetapir (AV45): 1.48 SUVR (profound elevated); Amyloid beta: 749.90 pg/mL (normal ); Total tau: 320.40 pg/mL (mild elevated); Phosphorylated tau: 29.25 pg/mL (mild elevated). ",
  "true_diagnosis": "Diagnosis: AD.",
  "gpt_diagnosis": "**Reasoning:** The imaging data shows significant atrophy in key Alzheimer's-related regions (hippocampus, entorhinal cortex, fusiform gyrus, middle temporal gyrus), alongside mild ventricular enlargement and moderate whole-brain atrophy. The clinical profile includes borderline MMSE (25) and low MoCA (13), with normal Aβ but elevated tau and AV45 (suggesting tauopathy and neurodegeneration despite no amyloid burden).  \n\n**Diagnosis:** **Dementia** (likely non-AD tauopathy, e.g., primary age-related tauopathy [PART] or another neurodegenerative process given the discordant biomarkers).  \n\n**Confidence:** **Medium** (high confidence in neurodegeneration/dementia, but low confidence in exact etiology due to atypical biomarker pattern).  \n\n**Note:** The profound atrophy in memory-related regions and low MoCA strongly suggest dementia, but the absence of APOE4 and normal Aβ makes typical AD less likely. The elevated tau/AV45 points to an alternative tau-driven pathology.",
  "timestamp": "2025-07-25T21:24:25.596091"
}